Skip to content
Review Open access

HSV-1 metabolic hijacking: Mechanisms to precision therapeutics

Aug 2026 · Virulence · Vol 17 · 0 citations · 194 references
Medicine

TL;DR

This review highlights that a systematic understanding of HSV-1-induced immunometabolic dysregulation reveals novel therapeutic targets, and offers a promising precision medicine approach against HSV-1 infection and related pathologies.

Abstract

ABSTRACT Herpes Simplex Virus Type 1 (HSV-1) strategically reprograms host cell metabolism to fulfill its replicative needs and establish persistent infection. This hijacking extends across glucose, lipid, amino acid, and nucleotide pathways, diverting resources toward viral biosynthesis. Critically, the resulting metabolic landscape is not neutral but actively immunosuppressive. By altering the availability of key metabolites and cellular energy states, HSV-1 impairs the function of innate and adaptive immune cells, including antigen presentation by dendritic cells and the effector response of T cells, thereby enabling immune evasion. This review highlights that a systematic understanding of HSV-1-induced immunometabolic dysregulation reveals novel therapeutic targets. Exploiting these metabolic vulnerabilities – through pharmacological intervention or engineered oncolytic viruses – offers a promising precision medicine approach against HSV-1 infection and related pathologies.

Read PDF

Similar papers

Review Open access Sep 2026

Syncytium-forming HSV-1 in cancer gene therapy: From molecular mechanisms to clinical translation

ABSTRACT Gene therapy has emerged as a promising strategy for cancer treatment, yet challenges in efficient gene delivery remain a major barrier. Herpes simplex virus type 1 (HSV-1), as an oncolytic virus, has garnered attention for its potential in cancer therapy due to its replicative capacity, large genomic payload,...

Xiang-Qian Zhao, Hu-Cheng Zhang, Shu-Zhen Xu et al. · 0 citations
Open access Sep 2026

Mechanistic inhibition of herpes simplex virus-1 UL21 immune-evasion function by natural-product scaffolds: A multi-tier docking, dynamics, and energetic profiling approach

These findings identify natural-product scaffolds with high potential to modulate UL21-mediated immune suppression, with kaempferol 3,7,4′-tri-O-β-glucoside emerging as the most promising candidate and provide a foundation for experimental validation and future antiviral drug development targeting HSV-1.

Muhammad Suleman, Imtiaz Ali, A. M. Sayaf et al. · 0 citations
Review Open access Aug 2026

Viral manipulation of DNA damage response signaling: molecular mechanisms and therapeutic implications.

The DNA damage response (DDR) network maintains genomic integrity, functions as a signaling hub that viruses exploit to drive pathogenesis, and constitutes a central interface between viral infection and host cell fate. This review discusses the molecular mechanisms by which viruses subvert host DDR pathways, with an e...

Mingyue Song, Shu-Yi Wang, Xiao Fei et al. · 0 citations
Review Aug 2026

Mechanisms of 'metabolizeaccretion' and therapeutic targets in influenza infection.

Influenza virus infection remains a leading cause of acute respiratory illness worldwide, with increasing resistance to conventional antiviral therapies highlighting the need for novel therapeutic strategies. This review introduces the concept of metabolizeaccretion, a self-reinforcing pathological cascade driven by me...

Ke-Xin Wang, Yue-Peng Li, Xiao-Hong Chen et al. · 0 citations
Review Open access Oct 2026

Manipulation of the cell cycle by HIV-1

Abstract Many viruses manipulate the host cell cycle to enhance viral replication and promote their evasion of host immune defenses. Human immunodeficiency virus type 1 (HIV-1) is no exception and triggers cell cycle arrest during its infection of replicating CD4+ T cells, acting predominantly through the activities of...

Madison Bandini, N. Sherer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.